Furthermore, CCNA2 expression decreased upon both C28 and SAL treatment, but this reduction did not reach statistical significance (Fig.
← all excerpts
Induction of cellular senescence by androgen receptor agonist or antagonist is mediated via two novel common DYRK1A-DREAM and cyclin G2 signaling pathways in castration-resistant prostate cancer.
1
—
—